###begin article-title 0
AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands
###end article-title 0
###begin p 1
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
###xml 879 887 <span type="species:ncbi:9606">patients</span>
###xml 992 1000 <span type="species:ncbi:9606">patients</span>
Congenital myasthenic syndromes are a clinically and genetically heterogeneous group of hereditary disorders affecting neuromuscular transmission. We have identified mutations within the acetylcholine receptor (AChR) epsilon-subunit gene underlying congenital myasthenic syndromes in nine patients (seven kinships) of Dutch origin. Previously reported mutations epsilon1369delG and epsilonR311Q were found to be common; epsilon1369delG was present on at least one allele in seven of the nine patients, and epsilonR311Q in six. Phenotypes ranged from relatively mild ptosis and external ophthalmoplegia to generalized myasthenia. The common occurrence of epsilonR311Q and epsilon1369delG suggests a possible founder for each of these mutations originating in North Western Europe, possibly in Holland. Knowledge of the ethnic or geographic origin within Europe of AChR deficiency patients can help in targeting genetic screening and it may be possible to provide a rapid genetic diagnosis for patients of Dutch origin by screening first for epsilonR311Q and epsilon1369delG.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s00415-009-5190-7) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 836 837 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 928 929 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 931 932 925 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 934 935 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 187 195 <span type="species:ncbi:9606">Patients</span>
The congenital myasthenic syndromes (CMSs) are a group of hereditary disorders affecting neuromuscular transmission [1-3]. The disorders are clinically and genetically heterogeneous [4]. Patients frequently present at birth or within the first two years of life. Most present with ocular, bulbar or respiratory muscle symptoms, worsened by crying or activity. The majority of CMSs primarily affect postsynaptic function, and are caused by mutations in subunits of the acetylcholine receptor (AChR), in the AChR-clustering protein rapsyn, or in DOK7. The AChR mutations may alter kinetic properties (slow- and fast-channel syndromes), decrease expression of the AChR pentamer (AChR deficiency) [5] or alter kinetic properties and decrease expression. Many mutations that decrease AChR expression reside in the AChR epsilon-subunit gene [6], with the resulting AChR deficiency phenotype inherited as an autosomal-recessive trait [3, 5, 7].
###end p 6
###begin p 7
###xml 72 79 <span type="species:ncbi:9606">infants</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
CMSs are relatively rare disorders that may be difficult to diagnose in infants and early childhood. Many of the AChR epsilon-subunit gene mutations are restricted to a single or only a few kinships. Consequently, genetic screening for AChR deficiency frequently requires thorough analysis of the whole of the epsilon-subunit gene. Here we present the cases of nine patients (seven kinships) for whom the diagnosis of congenital myasthenia has recently been confirmed by genetic analysis. We find a common occurrence of mutations epsilonR311Q and epsilon1369delG in AChR deficiency patients of Dutch origin.
###end p 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 8
###begin p 9
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 593 600 593 600 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 600 713 600 701 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="10">Patients with congenital myasthenic syndrome in the Netherlands and &#949;1369delG and/or &#949;R311Q mutations</p>
###xml 600 713 600 701 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="10">Patients with congenital myasthenic syndrome in the Netherlands and &#949;1369delG and/or &#949;R311Q mutations</p></caption>
###xml 713 727 701 715 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient number</th>
###xml 727 747 715 735 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age at onset (years)</th>
###xml 747 750 735 738 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sex</th>
###xml 750 774 738 762 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age at diagnosis (years)</th>
###xml 774 788 762 776 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">First symptoms</th>
###xml 788 806 776 794 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Actual age (years)</th>
###xml 806 821 794 809 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Actual symptoms</th>
###xml 821 865 809 847 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Mutations found in AChR &#949;-subunit gene</th>
###xml 713 865 701 847 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Patient number</th><th align="left">Age at onset (years)</th><th align="left">Sex</th><th align="left">Age at diagnosis (years)</th><th align="left">First symptoms</th><th align="left">Actual age (years)</th><th align="left">Actual symptoms</th><th align="left" colspan="2">Mutations found in AChR &#949;-subunit gene</th></tr>
###xml 713 865 701 847 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Patient number</th><th align="left">Age at onset (years)</th><th align="left">Sex</th><th align="left">Age at diagnosis (years)</th><th align="left">First symptoms</th><th align="left">Actual age (years)</th><th align="left">Actual symptoms</th><th align="left" colspan="2">Mutations found in AChR &#949;-subunit gene</th></tr></thead>
###xml 865 866 847 848 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 866 871 848 853 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Birth</td>
###xml 871 875 853 857 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 875 876 857 858 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 876 877 858 859 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P</td>
###xml 877 879 859 861 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 879 889 861 871 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, B, L</td>
###xml 889 904 871 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 904 928 880 892 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311 &#949;R311Q</td>
###xml 865 928 847 892 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P</td><td align="left">14</td><td align="left">P, O, B, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311 &#949;R311Q</td></tr>
###xml 928 929 892 893 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 929 930 893 894 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 930 934 894 898 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 934 935 898 899 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 935 939 899 903 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O</td>
###xml 939 940 903 904 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 940 944 904 908 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O</td>
###xml 944 959 908 917 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 959 971 917 923 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 928 971 892 923 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">2</td><td align="left">2</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P, O</td><td align="left">9</td><td align="left">P, O</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr>
###xml 971 972 923 924 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 972 977 924 929 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Birth</td>
###xml 977 983 929 935 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 983 984 935 936 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7</td>
###xml 984 985 936 937 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P</td>
###xml 985 987 937 939 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48</td>
###xml 987 994 939 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 994 1009 946 955 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 1009 1024 955 964 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 971 1024 923 964 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">3</td><td align="left">Birth</td><td align="left">Female</td><td char="." align="char">7</td><td align="left">P</td><td align="left">48</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;1369delG</td></tr>
###xml 1024 1025 964 965 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4</td>
###xml 1025 1030 965 970 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Birth</td>
###xml 1030 1034 970 974 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 1034 1035 974 975 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4</td>
###xml 1035 1036 975 976 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B</td>
###xml 1036 1038 976 978 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24</td>
###xml 1038 1045 978 985 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 1045 1060 985 994 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 1060 1075 994 1003 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949; 509insA</td>
###xml 1024 1075 964 1003 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">4</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">4</td><td align="left">B</td><td align="left">24</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; 509insA</td></tr>
###xml 1075 1076 1003 1004 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5</td>
###xml 1076 1077 1004 1005 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1077 1083 1005 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 1083 1085 1011 1013 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">54</td>
###xml 1085 1086 1013 1014 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P</td>
###xml 1086 1088 1014 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">74</td>
###xml 1088 1095 1016 1023 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 1095 1110 1023 1032 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 1110 1122 1032 1038 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 1075 1122 1003 1038 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">5</td><td align="left">1</td><td align="left">Female</td><td char="." align="char">54</td><td align="left">P</td><td align="left">74</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr>
###xml 1122 1123 1038 1039 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6</td>
###xml 1123 1124 1039 1040 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 1124 1128 1040 1044 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 1128 1130 1044 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">38</td>
###xml 1130 1131 1046 1047 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P</td>
###xml 1131 1133 1047 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">80</td>
###xml 1133 1140 1049 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O. L</td>
###xml 1140 1155 1056 1065 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 1155 1167 1065 1071 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 1122 1167 1038 1071 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">6</td><td align="left">3</td><td align="left">Male</td><td char="." align="char">38</td><td align="left">P</td><td align="left">80</td><td align="left">P, O. L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr>
###xml 1167 1168 1071 1072 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7</td>
###xml 1168 1173 1072 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Birth</td>
###xml 1173 1177 1077 1081 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 1177 1178 1081 1082 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8</td>
###xml 1178 1182 1082 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, B</td>
###xml 1182 1184 1086 1088 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38</td>
###xml 1184 1191 1088 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 1191 1203 1095 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 1203 1215 1101 1107 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 1167 1215 1071 1107 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">7</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">8</td><td align="left">P, B</td><td align="left">38</td><td align="left">P, O, L</td><td align="left">&#949;R311Q</td><td align="left">&#949;R311Q</td></tr>
###xml 1215 1216 1107 1108 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 1216 1223 1108 1115 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Infancy</td>
###xml 1223 1227 1115 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 1227 1229 1119 1121 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">18</td>
###xml 1229 1230 1121 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B</td>
###xml 1230 1232 1122 1124 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">32</td>
###xml 1232 1239 1124 1131 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 1239 1254 1131 1140 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;1369delG</td>
###xml 1254 1266 1140 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949; Y15H</td>
###xml 1215 1266 1107 1146 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">8</td><td align="left">Infancy</td><td align="left">Male</td><td char="." align="char">18</td><td align="left">B</td><td align="left">32</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; Y15H</td></tr>
###xml 1266 1267 1146 1147 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 1267 1274 1147 1154 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Infancy</td>
###xml 1274 1280 1154 1160 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 1280 1282 1160 1162 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50</td>
###xml 1282 1283 1162 1163 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P</td>
###xml 1283 1285 1163 1165 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">53</td>
###xml 1285 1292 1165 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P, O, L</td>
###xml 1292 1304 1172 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949; R64X</td>
###xml 1304 1316 1178 1184 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#949;R311Q</td>
###xml 1266 1316 1146 1184 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">9</td><td align="left">Infancy</td><td align="left">Female</td><td char="." align="char">50</td><td align="left">P</td><td align="left">53</td><td align="left">P, O, L</td><td align="left">&#949; R64X</td><td align="left">&#949;R311Q</td></tr>
###xml 865 1316 847 1184 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">1</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P</td><td align="left">14</td><td align="left">P, O, B, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311 &#949;R311Q</td></tr><tr><td align="left">2</td><td align="left">2</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P, O</td><td align="left">9</td><td align="left">P, O</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">3</td><td align="left">Birth</td><td align="left">Female</td><td char="." align="char">7</td><td align="left">P</td><td align="left">48</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;1369delG</td></tr><tr><td align="left">4</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">4</td><td align="left">B</td><td align="left">24</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; 509insA</td></tr><tr><td align="left">5</td><td align="left">1</td><td align="left">Female</td><td char="." align="char">54</td><td align="left">P</td><td align="left">74</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">6</td><td align="left">3</td><td align="left">Male</td><td char="." align="char">38</td><td align="left">P</td><td align="left">80</td><td align="left">P, O. L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">7</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">8</td><td align="left">P, B</td><td align="left">38</td><td align="left">P, O, L</td><td align="left">&#949;R311Q</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">8</td><td align="left">Infancy</td><td align="left">Male</td><td char="." align="char">18</td><td align="left">B</td><td align="left">32</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; Y15H</td></tr><tr><td align="left">9</td><td align="left">Infancy</td><td align="left">Female</td><td char="." align="char">50</td><td align="left">P</td><td align="left">53</td><td align="left">P, O, L</td><td align="left">&#949; R64X</td><td align="left">&#949;R311Q</td></tr></tbody>
###xml 713 1316 701 1184 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Patient number</th><th align="left">Age at onset (years)</th><th align="left">Sex</th><th align="left">Age at diagnosis (years)</th><th align="left">First symptoms</th><th align="left">Actual age (years)</th><th align="left">Actual symptoms</th><th align="left" colspan="2">Mutations found in AChR &#949;-subunit gene</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P</td><td align="left">14</td><td align="left">P, O, B, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311 &#949;R311Q</td></tr><tr><td align="left">2</td><td align="left">2</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P, O</td><td align="left">9</td><td align="left">P, O</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">3</td><td align="left">Birth</td><td align="left">Female</td><td char="." align="char">7</td><td align="left">P</td><td align="left">48</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;1369delG</td></tr><tr><td align="left">4</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">4</td><td align="left">B</td><td align="left">24</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; 509insA</td></tr><tr><td align="left">5</td><td align="left">1</td><td align="left">Female</td><td char="." align="char">54</td><td align="left">P</td><td align="left">74</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">6</td><td align="left">3</td><td align="left">Male</td><td char="." align="char">38</td><td align="left">P</td><td align="left">80</td><td align="left">P, O. L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">7</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">8</td><td align="left">P, B</td><td align="left">38</td><td align="left">P, O, L</td><td align="left">&#949;R311Q</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">8</td><td align="left">Infancy</td><td align="left">Male</td><td char="." align="char">18</td><td align="left">B</td><td align="left">32</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; Y15H</td></tr><tr><td align="left">9</td><td align="left">Infancy</td><td align="left">Female</td><td char="." align="char">50</td><td align="left">P</td><td align="left">53</td><td align="left">P, O, L</td><td align="left">&#949; R64X</td><td align="left">&#949;R311Q</td></tr></tbody></table>
###xml 1316 1317 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1326 1327 1194 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1354 1355 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1373 1374 1241 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 1316 1388 1184 1256 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="11"><italic>P</italic> ptosis, <italic>O</italic> external ophthalmoplegia, <italic>B</italic> bulbar symptoms, <italic>L</italic> limb weakness</p>
###xml 1316 1388 1184 1256 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="11"><italic>P</italic> ptosis, <italic>O</italic> external ophthalmoplegia, <italic>B</italic> bulbar symptoms, <italic>L</italic> limb weakness</p></table-wrap-foot>
###xml 593 1388 593 1256 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="10">Patients with congenital myasthenic syndrome in the Netherlands and &#949;1369delG and/or &#949;R311Q mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient number</th><th align="left">Age at onset (years)</th><th align="left">Sex</th><th align="left">Age at diagnosis (years)</th><th align="left">First symptoms</th><th align="left">Actual age (years)</th><th align="left">Actual symptoms</th><th align="left" colspan="2">Mutations found in AChR &#949;-subunit gene</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P</td><td align="left">14</td><td align="left">P, O, B, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311 &#949;R311Q</td></tr><tr><td align="left">2</td><td align="left">2</td><td align="left">Male</td><td char="." align="char">2</td><td align="left">P, O</td><td align="left">9</td><td align="left">P, O</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">3</td><td align="left">Birth</td><td align="left">Female</td><td char="." align="char">7</td><td align="left">P</td><td align="left">48</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;1369delG</td></tr><tr><td align="left">4</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">4</td><td align="left">B</td><td align="left">24</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; 509insA</td></tr><tr><td align="left">5</td><td align="left">1</td><td align="left">Female</td><td char="." align="char">54</td><td align="left">P</td><td align="left">74</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">6</td><td align="left">3</td><td align="left">Male</td><td char="." align="char">38</td><td align="left">P</td><td align="left">80</td><td align="left">P, O. L</td><td align="left">&#949;1369delG</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">7</td><td align="left">Birth</td><td align="left">Male</td><td char="." align="char">8</td><td align="left">P, B</td><td align="left">38</td><td align="left">P, O, L</td><td align="left">&#949;R311Q</td><td align="left">&#949;R311Q</td></tr><tr><td align="left">8</td><td align="left">Infancy</td><td align="left">Male</td><td char="." align="char">18</td><td align="left">B</td><td align="left">32</td><td align="left">P, O, L</td><td align="left">&#949;1369delG</td><td align="left">&#949; Y15H</td></tr><tr><td align="left">9</td><td align="left">Infancy</td><td align="left">Female</td><td char="." align="char">50</td><td align="left">P</td><td align="left">53</td><td align="left">P, O, L</td><td align="left">&#949; R64X</td><td align="left">&#949;R311Q</td></tr></tbody></table><table-wrap-foot><p textid="11"><italic>P</italic> ptosis, <italic>O</italic> external ophthalmoplegia, <italic>B</italic> bulbar symptoms, <italic>L</italic> limb weakness</p></table-wrap-foot></table-wrap>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 111 119 <span type="species:ncbi:9606">Patients</span>
###xml 270 278 <span type="species:ncbi:9606">Patients</span>
###xml 486 494 <span type="species:ncbi:9606">patients</span>
###xml 501 509 <span type="species:ncbi:9606">patients</span>
We identified nine CMS patients in the Netherlands (Table 1). All patients were of Dutch origin and Caucasian. Patients 3-8 have been reported before by the late Dr. Oosterhuis before mutation analysis was performed [8]. Antibodies to the AChR were absent in all cases. Patients generally presented with ptosis and ophthalmoparesis from infancy or early childhood. Some of them had swallowing difficulties or proximal muscle weakness later on. Neostigmine had a moderate effect in most patients. Some patients remained stable throughout life, whereas others slowly declined in muscle strength.Table 1Patients with congenital myasthenic syndrome in the Netherlands and epsilon1369delG and/or epsilonR311Q mutationsPatient numberAge at onset (years)SexAge at diagnosis (years)First symptomsActual age (years)Actual symptomsMutations found in AChR epsilon-subunit gene1BirthMale2P14P, O, B, Lepsilon1369delGepsilonR311 epsilonR311Q22Male2P, O9P, Oepsilon1369delGepsilonR311Q3BirthFemale7P48P, O, Lepsilon1369delGepsilon1369delG4BirthMale4B24P, O, Lepsilon1369delGepsilon 509insA51Female54P74P, O, Lepsilon1369delGepsilonR311Q63Male38P80P, O. Lepsilon1369delGepsilonR311Q7BirthMale8P, B38P, O, LepsilonR311QepsilonR311Q8InfancyMale18B32P, O, Lepsilon1369delGepsilon Y15H9InfancyFemale50P53P, O, Lepsilon R64XepsilonR311QP ptosis, O external ophthalmoplegia, B bulbar symptoms, L limb weakness
###end p 9
###begin p 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with congenital myasthenic syndrome in the Netherlands and epsilon1369delG and/or epsilonR311Q mutations
###end p 10
###begin p 11
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
P ptosis, O external ophthalmoplegia, B bulbar symptoms, L limb weakness
###end p 11
###begin p 12
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 1,</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 25 28 <span type="species:ncbi:9606">boy</span>
Patient 1, a 14-year-old boy with non-consanguine parents, presented at the age of two and a half years with ptosis and ophthalmoparesis. The ptosis had been present from birth. He remained stable until the age of 10, when he presented with a rapid progressive weakness involving his arms, legs and bulbar muscles, following a flu-like disease. These symptoms resolved spontaneously after a few days. He improved after administration of neostigmine. Repetitive nerve stimulation showed no decrement of compound muscle action potentials (CMAPs), nor repetitive CMAPs.
###end p 12
###begin p 13
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 2</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 36 43 <span type="species:ncbi:9606">patient</span>
Patient 2 is the younger brother of patient 1, who according to the parents had symptoms of ophthalmoparesis and ptosis at the age of two years. No muscle weakness of arms or legs was noted. His parents did not request further investigations to be made. His current age is 9 years, and he has apparently been stable so far.
###end p 13
###begin p 14
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 3</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient 3 had drooping eyelids from early infancy, and was never able to run. At the age of 23 she had ptosis at both eyes, a nearly complete ophthalmoplegia, mild facial weakness and mild weakness of the limbs. She improved after treatment with neostigmine. During the following years her symptoms remained unchanged.
###end p 14
###begin p 15
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 4</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 27 30 <span type="species:ncbi:9606">man</span>
###xml 208 212 <span type="species:ncbi:9606">boys</span>
Patient 4 is a 24-year-old man who has had swallowing difficulties from birth. At the time of the biopsy (when he was 5 years old) he had drooping eyelids and difficulties with swallowing. Running with other boys was difficult. Neostigmine, and later mytelase was given from 4 years onwards which provided some improvement. On his last neurologic examination in 2004 he still used neostigmine, with a moderate effect, and his symptoms remained unchanged. Repetitive nerve stimulation showed a decrement of CMAPs.
###end p 15
###begin p 16
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 5,</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 25 30 <span type="species:ncbi:9606">woman</span>
###xml 173 181 <span type="species:ncbi:9606">children</span>
Patient 5, a 74-year-old woman with unrelated parents, had drooping eyelids from the age of 1 year. Mild generalised weakness especially in arms and hands, impeded her with children's games. At 15 years myasthenia gravis was diagnosed and pyridostigmine was found to have a beneficial effect. Her condition gradually worsened and when she was 51 years old she had diplopia, chewing difficulties and outdoors she became wheelchair dependent. At the time of the biopsy (when she was 58 years old) the muscle bulk was very small, with weakness of the deltoid, arm and leg muscles. The 5th CMAP (3 Hz) of the abductor pollicis brevis showed a 10% decrement. In the following 17 years the generalised weakness progressed further.
###end p 16
###begin p 17
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 6</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 26 29 <span type="species:ncbi:9606">man</span>
###xml 42 49 <span type="species:ncbi:9606">patient</span>
Patient 6, an 80-year-old man (brother of patient 5) had drooping eyelids from early childhood. He had dyspnea after climbing the stairs while he was at primary school. There were no diurnal fluctuations of symptoms, but there were bad days, especially when it was cold. He responded well to treatment with pyridostigmine, which was initiated only when he was 60 years old. At the time of the biopsy (when he was 64 years old) the muscle bulk was small but without obvious atrophy. He could not rise from his chair without the help from his arms. The 5th CMAP (3 Hz) of the abductor digiti minimi muscle showed a 10% decrement. In the following 20 years the generalised weakness progressed further.
###end p 17
###begin p 18
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 7</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 27 30 <span type="species:ncbi:9606">man</span>
Patient 7 is a 38-year-old man who had drooping eyelids and weak facial muscles since birth. At the time of the biopsy (when he was 19 years old) he had double vision in the morning, ptosis, and diffuse weakness of the limbs.
###end p 18
###begin p 19
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 8</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 27 30 <span type="species:ncbi:9606">man</span>
Patient 8 is a 32-year-old man who experienced feeding difficulties due to a weak suck after birth. At the end of his first year he developed drooping eyelids. At the age of 4 years he developed limb weakness. He was never able to stand up without aid of his hand, and could not run. At the age of 18 years he had generalized proximal weakness of his limbs, ptosis, and intermittent diplopia.
###end p 19
###begin p 20
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 9</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 27 32 <span type="species:ncbi:9606">woman</span>
Patient 9 is a 53-year-old woman with symmetrical ptosis without double vision since infancy and walking difficulties in childhood. She had to drink with her meals to make swallowing easier. At the age of 50 years she had severe ptosis with very restricted eye movements and sometimes double vision. She is quickly tired in her limbs and is unable to rise from a chair without support. Her fatigue disappeared completely with pyridostigmine.
###end p 20
###begin title 21
Genetic analysis
###end title 21
###begin p 22
###xml 673 674 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 17 24 <span type="species:ncbi:9606">patient</span>
Genomic DNA from patient and control samples was isolated from peripheral blood using the Nucleontrade mark II DNA extraction kit (Nucleon Biosciences). Coding exons and regions of the promoter of the AChR epsilon-subunit gene were amplified using the polymerase chain reaction (PCR) and amplicons screened for mutations by direct DNA sequencing. DNA changes were confirmed by restriction endonuclease digestion and size fractionation by agarose gel electrophoresis. The detected mutations were not observed in restriction digests of 100 control samples. Functional effects of the missense mutations were confirmed by studies of the mutant AChR expressed in HEK 293 cells [9].
###end p 22
###begin p 23
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8242;</sup>
Oligonucleotides 5'-CAAACAGGATATCCAAGGCCACTAC-3' and 5'-CTTCCCCCAAACTCCAGGGAATGGAG-3' were used in PCR reactions to amplify a section of the CHRNE 3' untranslated region that harbours a cluster of SNPs ().
###end p 23
###begin p 24
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Haplotypes were determined by DNA sequence analysis of CMS patients and relatives. Gene frequency for the G or C nucleotide at SNP rs9914357 was determined by DNA sequencing of 100 control chromosomes. SNPs with minor allele frequency >25% (CEPH) were selected.
###end p 24
###begin p 25
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNE</italic>
Data from screening over 100 suspected CMS cases of Northern European origin that did not have CHRNE mutations gave similar allele frequencies to the CEPH population.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Mutation analysis
###end title 27
###begin p 28
###xml 90 95 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNE</italic>
###xml 432 433 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 727 728 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 735 736 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 834 840 738 744 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 840 841 744 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 990 996 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shaded</italic>
###xml 1117 1118 1015 1016 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 840 1429 744 1327 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><bold>a</bold> Restriction endonuclease digests of PCR amplicons of the AChR &#949;-subunit gene exons 9 and 12 amplified from genomic DNA. Affected individuals (<italic>shaded</italic>) in the kinship (patients 1 and 2) carry two mutant alleles, whereas members carrying one (half-shaded) are unaffected. <bold>b</bold> Example of SNP haplotypes within the 3&#8242; untranslated region of CHRNE showing the kinship containing patients 1 and 2, derived by DNA sequencing of genomic DNA from family members. Haplotype T A T G is seen to associate with the allele harbouring e1369delG and haplotype G A G C with the allele harbouring R311Q</p>
###xml 840 1429 744 1327 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><bold>a</bold> Restriction endonuclease digests of PCR amplicons of the AChR &#949;-subunit gene exons 9 and 12 amplified from genomic DNA. Affected individuals (<italic>shaded</italic>) in the kinship (patients 1 and 2) carry two mutant alleles, whereas members carrying one (half-shaded) are unaffected. <bold>b</bold> Example of SNP haplotypes within the 3&#8242; untranslated region of CHRNE showing the kinship containing patients 1 and 2, derived by DNA sequencing of genomic DNA from family members. Haplotype T A T G is seen to associate with the allele harbouring e1369delG and haplotype G A G C with the allele harbouring R311Q</p></caption>
###xml 1429 1429 1327 1327 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="415_2009_5190_Fig1_HTML" id="MO1"/>
###xml 834 1429 738 1327 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="29"><bold>a</bold> Restriction endonuclease digests of PCR amplicons of the AChR &#949;-subunit gene exons 9 and 12 amplified from genomic DNA. Affected individuals (<italic>shaded</italic>) in the kinship (patients 1 and 2) carry two mutant alleles, whereas members carrying one (half-shaded) are unaffected. <bold>b</bold> Example of SNP haplotypes within the 3&#8242; untranslated region of CHRNE showing the kinship containing patients 1 and 2, derived by DNA sequencing of genomic DNA from family members. Haplotype T A T G is seen to associate with the allele harbouring e1369delG and haplotype G A G C with the allele harbouring R311Q</p></caption><graphic position="anchor" xlink:href="415_2009_5190_Fig1_HTML" id="MO1"/></fig>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 755 763 <span type="species:ncbi:9606">patients</span>
###xml 1014 1022 <span type="species:ncbi:9606">patients</span>
###xml 1219 1227 <span type="species:ncbi:9606">patients</span>
Screening of DNA from patients 1-9 identified mutations in the AChR epsilon-subunit gene (CHRNE). Five different mutations were identified: epsilonY15H, epsilonR64X, epsilon509insA, epsilonR311Q, epsilon1369delG. Previous functional studies of these mutations have shown that epsilonR311Q results in severely reduced expression of adult-type AChR with near normal ion-channel properties, whereas epsilon1369delG is a null mutation [9]. Four patients (two were siblings) are compound heterozygous for epsilonR311Q/epsilon1369delG, one is homozygous for epsilonR311Q, one homozygous for epsilon1369delG, two harbour a null allele in combination with epsilon1369delG, and one a null allele in combination with epsilonR311Q (Table 1; Fig. 1). Strikingly, all patients harboured at least one copy of either epsilonR311Q or epsilon1369delG.Fig. 1a Restriction endonuclease digests of PCR amplicons of the AChR epsilon-subunit gene exons 9 and 12 amplified from genomic DNA. Affected individuals (shaded) in the kinship (patients 1 and 2) carry two mutant alleles, whereas members carrying one (half-shaded) are unaffected. b Example of SNP haplotypes within the 3' untranslated region of CHRNE showing the kinship containing patients 1 and 2, derived by DNA sequencing of genomic DNA from family members. Haplotype T A T G is seen to associate with the allele harbouring e1369delG and haplotype G A G C with the allele harbouring R311Q
###end p 28
###begin p 29
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 150 156 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shaded</italic>
###xml 277 278 271 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
a Restriction endonuclease digests of PCR amplicons of the AChR epsilon-subunit gene exons 9 and 12 amplified from genomic DNA. Affected individuals (shaded) in the kinship (patients 1 and 2) carry two mutant alleles, whereas members carrying one (half-shaded) are unaffected. b Example of SNP haplotypes within the 3' untranslated region of CHRNE showing the kinship containing patients 1 and 2, derived by DNA sequencing of genomic DNA from family members. Haplotype T A T G is seen to associate with the allele harbouring e1369delG and haplotype G A G C with the allele harbouring R311Q
###end p 29
###begin title 30
Haplotype analysis
###end title 30
###begin p 31
###xml 278 283 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNE</italic>
###xml 369 370 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 377 378 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 476 477 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 534 535 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 547 554 529 536 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 554 663 536 645 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Analysis of SNPs clustered in 3&#8242; untranslated region of CHRNE in Dutch patients with AChR deficiency syndrome</p>
###xml 554 663 536 645 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">Analysis of SNPs clustered in 3&#8242; untranslated region of CHRNE in Dutch patients with AChR deficiency syndrome</p></caption>
###xml 663 670 645 652 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Patient</th>
###xml 670 673 652 655 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">SNP</th>
###xml 663 673 645 655 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Patient</th><th align="left" colspan="6">SNP</th></tr>
###xml 673 682 655 664 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs1053754</th>
###xml 682 688 664 670 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs8834</th>
###xml 688 694 670 676 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs7774</th>
###xml 694 703 676 685 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">rs9914357</th>
###xml 703 711 685 693 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mutation</th>
###xml 711 719 693 701 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mutation</th>
###xml 673 719 655 701 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">rs1053754</th><th align="left">rs8834</th><th align="left">rs7774</th><th align="left">rs9914357</th><th align="left">Mutation</th><th align="left">Mutation</th></tr>
###xml 663 719 645 701 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Patient</th><th align="left" colspan="6">SNP</th></tr><tr><th align="left">rs1053754</th><th align="left">rs8834</th><th align="left">rs7774</th><th align="left">rs9914357</th><th align="left">Mutation</th><th align="left">Mutation</th></tr></thead>
###xml 719 720 701 702 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 720 723 702 705 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 723 726 705 708 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 726 729 708 711 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 729 732 711 714 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C</td>
###xml 732 740 714 722 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 740 745 722 727 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 719 745 701 727 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr>
###xml 745 746 727 728 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 746 749 728 731 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 749 752 731 734 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 752 755 734 737 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 755 758 737 740 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C</td>
###xml 758 766 740 748 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 766 771 748 753 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 745 771 727 753 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">2</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr>
###xml 771 772 753 754 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 772 775 754 757 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/T</td>
###xml 775 778 757 760 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 778 781 760 763 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/T</td>
###xml 781 784 763 766 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 784 792 766 774 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 792 800 774 782 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 771 800 753 782 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">3</td><td align="left">T/T</td><td align="left">A/A</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">1369delG</td></tr>
###xml 800 801 782 783 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4</td>
###xml 801 804 783 786 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 804 807 786 789 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/G</td>
###xml 807 810 789 792 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/T</td>
###xml 810 813 792 795 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 813 821 795 803 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 821 828 803 810 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">509insA</td>
###xml 800 828 782 810 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">4</td><td align="left">T/G</td><td align="left">A/G</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">509insA</td></tr>
###xml 828 829 810 811 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5</td>
###xml 829 832 811 814 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 832 835 814 817 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 835 838 817 820 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 838 841 820 823 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C</td>
###xml 841 849 823 831 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 849 854 831 836 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 828 854 810 836 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">5</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr>
###xml 854 855 836 837 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6</td>
###xml 855 858 837 840 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 858 861 840 843 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 861 864 843 846 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 864 867 846 849 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C</td>
###xml 867 875 849 857 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 875 880 857 862 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 854 880 836 862 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">6</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr>
###xml 880 881 862 863 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7</td>
###xml 881 884 863 866 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 884 887 866 869 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 887 890 869 872 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 890 893 872 875 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">C/C</td>
###xml 893 898 875 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 898 903 880 885 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 880 903 862 885 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">7</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">C/C</td><td align="left">R311Q</td><td align="left">R311Q</td></tr>
###xml 903 904 885 886 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 904 907 886 889 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 907 910 889 892 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 910 913 892 895 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G</td>
###xml 913 916 895 898 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 916 924 898 906 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1369delG</td>
###xml 924 928 906 910 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Y15H</td>
###xml 903 928 885 910 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">8</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">Y15H</td></tr>
###xml 928 929 910 911 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 929 932 911 914 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 932 935 914 917 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/A</td>
###xml 935 938 917 920 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/G</td>
###xml 938 941 920 923 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C</td>
###xml 941 945 923 927 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R64X</td>
###xml 945 950 927 932 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">R311Q</td>
###xml 928 950 910 932 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">9</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">G/C</td><td align="left">R64X</td><td align="left">R311Q</td></tr>
###xml 950 964 932 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heterozygosity</td>
###xml 964 969 946 951 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.471</td>
###xml 969 974 951 956 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.385</td>
###xml 974 979 956 961 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.481</td>
###xml 979 984 961 966 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.455</td>
###xml 984 984 966 966 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 984 984 966 966 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 950 984 932 966 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Heterozygosity</td><td align="left">0.471</td><td align="left">0.385</td><td align="left">0.481</td><td align="left">0.455</td><td align="left"/><td align="left"/></tr>
###xml 984 993 966 975 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Frequency</td>
###xml 993 1006 975 988 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G 0.62/0.38</td>
###xml 1006 1019 988 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A/G 0.74/0.26</td>
###xml 1019 1032 1001 1014 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T/G 0.60/0.40</td>
###xml 1032 1045 1014 1027 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G/C 0.65/0.35</td>
###xml 1045 1045 1027 1027 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1045 1045 1027 1027 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 984 1045 966 1027 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Frequency</td><td align="left">T/G 0.62/0.38</td><td align="left">A/G 0.74/0.26</td><td align="left">T/G 0.60/0.40</td><td align="left">G/C 0.65/0.35</td><td align="left"/><td align="left"/></tr>
###xml 719 1045 701 1027 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">1</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">2</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">3</td><td align="left">T/T</td><td align="left">A/A</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">1369delG</td></tr><tr><td align="left">4</td><td align="left">T/G</td><td align="left">A/G</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">509insA</td></tr><tr><td align="left">5</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">6</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">7</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">C/C</td><td align="left">R311Q</td><td align="left">R311Q</td></tr><tr><td align="left">8</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">Y15H</td></tr><tr><td align="left">9</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">G/C</td><td align="left">R64X</td><td align="left">R311Q</td></tr><tr><td align="left">Heterozygosity</td><td align="left">0.471</td><td align="left">0.385</td><td align="left">0.481</td><td align="left">0.455</td><td align="left"/><td align="left"/></tr><tr><td align="left">Frequency</td><td align="left">T/G 0.62/0.38</td><td align="left">A/G 0.74/0.26</td><td align="left">T/G 0.60/0.40</td><td align="left">G/C 0.65/0.35</td><td align="left"/><td align="left"/></tr></tbody>
###xml 663 1045 645 1027 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Patient</th><th align="left" colspan="6">SNP</th></tr><tr><th align="left">rs1053754</th><th align="left">rs8834</th><th align="left">rs7774</th><th align="left">rs9914357</th><th align="left">Mutation</th><th align="left">Mutation</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">2</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">3</td><td align="left">T/T</td><td align="left">A/A</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">1369delG</td></tr><tr><td align="left">4</td><td align="left">T/G</td><td align="left">A/G</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">509insA</td></tr><tr><td align="left">5</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">6</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">7</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">C/C</td><td align="left">R311Q</td><td align="left">R311Q</td></tr><tr><td align="left">8</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">Y15H</td></tr><tr><td align="left">9</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">G/C</td><td align="left">R64X</td><td align="left">R311Q</td></tr><tr><td align="left">Heterozygosity</td><td align="left">0.471</td><td align="left">0.385</td><td align="left">0.481</td><td align="left">0.455</td><td align="left"/><td align="left"/></tr><tr><td align="left">Frequency</td><td align="left">T/G 0.62/0.38</td><td align="left">A/G 0.74/0.26</td><td align="left">T/G 0.60/0.40</td><td align="left">G/C 0.65/0.35</td><td align="left"/><td align="left"/></tr></tbody></table>
###xml 547 1045 529 1027 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="32">Analysis of SNPs clustered in 3&#8242; untranslated region of CHRNE in Dutch patients with AChR deficiency syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Patient</th><th align="left" colspan="6">SNP</th></tr><tr><th align="left">rs1053754</th><th align="left">rs8834</th><th align="left">rs7774</th><th align="left">rs9914357</th><th align="left">Mutation</th><th align="left">Mutation</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">2</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">3</td><td align="left">T/T</td><td align="left">A/A</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">1369delG</td></tr><tr><td align="left">4</td><td align="left">T/G</td><td align="left">A/G</td><td align="left">T/T</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">509insA</td></tr><tr><td align="left">5</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">6</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/C</td><td align="left">1369delG</td><td align="left">R311Q</td></tr><tr><td align="left">7</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">C/C</td><td align="left">R311Q</td><td align="left">R311Q</td></tr><tr><td align="left">8</td><td align="left">T/G</td><td align="left">A/A</td><td align="left">T/G</td><td align="left">G/G</td><td align="left">1369delG</td><td align="left">Y15H</td></tr><tr><td align="left">9</td><td align="left">G/G</td><td align="left">A/A</td><td align="left">G/G</td><td align="left">G/C</td><td align="left">R64X</td><td align="left">R311Q</td></tr><tr><td align="left">Heterozygosity</td><td align="left">0.471</td><td align="left">0.385</td><td align="left">0.481</td><td align="left">0.455</td><td align="left"/><td align="left"/></tr><tr><td align="left">Frequency</td><td align="left">T/G 0.62/0.38</td><td align="left">A/G 0.74/0.26</td><td align="left">T/G 0.60/0.40</td><td align="left">G/C 0.65/0.35</td><td align="left"/><td align="left"/></tr></tbody></table></table-wrap>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
To investigate the possibility that epsilonR311Q and epsilon1369delG may be derived from original founder mutations we analysed a cluster of four single nucleotide polymorphisms (SNPs), rs1053754, rs8834, rs7774, rs9914357, that are located within the 3' untranslated region of CHRNE. Haplotypes for patients and family members for the four SNPs were determined (Table 2; Fig. 1b). In all cases mutation epsilon1369delG associated with the haplotype T A T G at the four SNPs (P = 0.001) and mutation R311Q with SNP haplotype G A G C (P = 0.00006).Table 2Analysis of SNPs clustered in 3' untranslated region of CHRNE in Dutch patients with AChR deficiency syndromePatientSNPrs1053754rs8834rs7774rs9914357MutationMutation1T/GA/AT/GG/C1369delGR311Q2T/GA/AT/GG/C1369delGR311Q3T/TA/AT/TG/G1369delG1369delG4T/GA/GT/TG/G1369delG509insA5T/GA/AT/GG/C1369delGR311Q6T/GA/AT/GG/C1369delGR311Q7G/GA/AG/GC/CR311QR311Q8T/GA/AT/GG/G1369delGY15H9G/GA/AG/GG/CR64XR311QHeterozygosity0.4710.3850.4810.455FrequencyT/G 0.62/0.38A/G 0.74/0.26T/G 0.60/0.40G/C 0.65/0.35
###end p 31
###begin p 32
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Analysis of SNPs clustered in 3' untranslated region of CHRNE in Dutch patients with AChR deficiency syndrome
###end p 32
###begin title 33
Intercostal muscle biopsy
###end title 33
###begin p 34
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</bold>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
Histological and electrophysiological characteristics of endplates from patients 4-7 are given in supplementary material. In patients 5 and 6 there was a reduction in the sensitivity of the endplates towards ACh and a decrease of the number of secondary synaptic clefts. However, in patients 4 and 7 the sensitivity of the endplates towards ACh was almost normal despite the clinical weakness, suggesting that in these patients the level of expression of the AChR gamma subunit is sufficient to effectively compensates for loss of the epsilon.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAPSN</italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNE</italic>
###xml 686 688 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 447 455 <span type="species:ncbi:9606">patients</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 655 662 <span type="species:ncbi:9606">patient</span>
To date, the Oxford Myasthenia Service has identified mutations that cause congenital myasthenic syndromes in 17 patients of Dutch origin. Four have mutations that cause slow channel syndrome, four have mutations in the RAPSN gene, and nine have mutations that underlie an AChR deficiency syndrome due to mutations within CHRNE. Mutation epsilon1369delG was present on at least one allele in seven of the nine epsilon-subunit gene AChR deficiency patients, and epsilonR311Q in six. At Oxford the epsilon1369delG and epsilonR311Q mutations have not been identified in patients with CMS from other ethnic origins, but epsilon1369delG has been reported in a patient from Northern Germany [10]. The common occurrence of epsilon1369delG and epsilonR311Q, and their strict association with the respective CHRNE SNP haplotypes (rs1053754-rs8834-rs7774-rs9914357: T A T G and G A G C) strongly suggests a founder for each of these mutations originating in North Western Europe, possibly in Holland.
###end p 36
###begin p 37
###xml 454 456 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 458 460 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
Most CMS with severe endplate AChR deficiency result from recessive mutations in AChR epsilon-subunit gene, or the gene encoding rapsyn. The mutations in the epsilon-subunit are found along the length of the gene, and result in frameshifts or nonsense codons that truncate the subunit polypeptide chain, or loss of residues essential for AChR assembly or function. More than 90 different AChR epsilon-subunit gene mutations have been described thus far [11, 12] (and D. Beeson, unpublished data).
###end p 37
###begin p 38
###xml 191 192 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 194 196 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 396 398 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 432 433 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 620 621 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 623 625 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 655 662 <span type="species:ncbi:9606">patient</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
Previous functional studies of the epsilon1369delG mutation, located close to the subunit C-terminus, have shown that it is not incorporated into cell surface AChR and thus is a null allele [9, 10]. Studies of epsilonR311Q show that it is incorporated into surface AChR pentamers although at severely reduced levels, and in contrast to another mutation identified in the same site, epsilonR311W [13], does not affect AChR kinetics [9]. It is thought that patients harbouring homozygous or heteroallelic epsilon-subunit null mutations show partial phenotypic rescue through residual expression of the AChR gamma-subunit [7, 13]. Interestingly, symptoms in patient 3, homozygous for epsilon1369delG, were not substantially more severe than in patients 1, 2, 5 and 6 who are heteroallelic for epsilon1369delG and epsilonR311Q.
###end p 38
###begin p 39
###xml 582 584 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 586 588 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
###xml 806 814 <span type="species:ncbi:9606">patients</span>
###xml 894 902 <span type="species:ncbi:9606">patients</span>
In many cases of AChR deficiency syndrome the kinship is found to have 'private' mutations and it may be necessary to screen the entire epsilon-subunit gene coding sequence. However, it is becoming clear that some epsilon-subunit gene mutations underlying AChR deficiency syndrome have an increased incidence in particular geographic regions, presumably arising from original founder mutations. The best examples of this are the 1293insG mutation arising in the Magreb population in North Africa, and in the Gypsy population of South Eastern Europe where epsilon1267delG is common [14, 15]. Here we highlight two mutations, epsilonR311Q and epsilon1369delG, that are common in AChR deficiency syndrome patients of Dutch origin. Knowledge of the ethnic or geographic origin within Europe of AChR deficiency patients can help in targeting genetic screening, and our results suggest that for many patients of Dutch origin, screening first for epsilonR311Q and epsilon1369delG may provide a rapid genetic diagnosis.
###end p 39
###begin title 40
Electronic supplementary material
###end title 40
###begin p 41
Below is the link to the electronic supplementary material. 
###end p 41
###begin p 42
Supplementary material 1 (DOCX 49 kb)
###end p 42
###begin p 43
We gratefully acknowledge support of the Prinses Beatrix Fonds (grant no MAR02-0204) to P. C.M. and support from the MRC and Myasthenia Gravis Association/Muscular Dystrophy Campaign to D.B.
###end p 43
###begin p 44
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Congenital myasthenic syndromes. Studies of the AChR and other candidate genes
###end article-title 46
###begin article-title 47
Molecular targets for autoimmune and genetic disorders of neuromuscular transmission
###end article-title 47
###begin article-title 48
Congenital myasthenic syndromes
###end article-title 48
###begin article-title 49
Congenital myasthenic syndromes: recent advances
###end article-title 49
###begin article-title 50
Congenital myasthenic syndromes: progress over the past decade
###end article-title 50
###begin article-title 51
End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations
###end article-title 51
###begin article-title 52
Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR
###end article-title 52
###begin article-title 53
Genetic analysis of the entire AChR epsilon-subunit gene in 52 congenital myasthenic families
###end article-title 53
###begin article-title 54
Current understanding of congenital myasthenic syndromes
###end article-title 54
###begin article-title 55
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations
###end article-title 55
###begin article-title 56
The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa
###end article-title 56
###begin article-title 57
###xml 61 69 <span type="species:ncbi:9606">patients</span>
A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin
###end article-title 57
###begin title 58
Abbreviations
###end title 58
###begin p 59
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
125I-alpha-Bungarotoxin
###end p 59
###begin p 60
Acetylcholine receptor
###end p 60
###begin p 61
AChR epsilon-subunit gene
###end p 61
###begin p 62
Congenital myasthenic syndrome
###end p 62
###begin p 63
Polymerase chain reaction
###end p 63
###begin p 64
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 64
###begin p 65
The online version of this article (doi:10.1007/s00415-009-5190-7) contains supplementary material, which is available to authorized users.
###end p 65

